Bortezomib Injection - taj logo
NORVELZO® (BORTEZOMIB FOR INJECTION) is used to treat multiple myeloma and mantle cell lymphoma NORVELZO® (BORTEZOMIB FOR INJECTION) is used to treat multiple myeloma and mantle cell lymphoma The Official Website for NORVELZO® (bortezomib Learn about the prescription medication NORVELZO (Bortezomib) drug uses dosage side effects drug interactions warnings reviews and patient labeling Consumer information about the medication BORTEZOMIB - INJECTION (Norvelzo) side effects medical uses and drug interactions manufacturer bortezomib injection tablets supplier bortezomib injection export import bortezomib mesylate Generic bortezomib injection tablets NORVELZO® (BORTEZOMIB FOR INJECTION) bortezomib injection bortezomib Norvelzo bortezomib (Norvelzo) side effects bortezomib (Norvelzo) interactions bortezomib (Norvelzo) dosing Norvelzo Bortezomib drug description chemical structure black box warning medications drugs generic fda approved patient labeling reviews professionals clinicians clinical Norvelzo for patients Norvelzo prescribing information Norvelzo package insert Norvelzo patient information Norvelzo PI Norvelzo information Norvelzo bortezomib for patients bortezomib prescribing information bortezomib package insert manufacturer bortezomib injection tablets supplier bortezomib injection export import bortezomib mesylate Generic bortezomib injection tablets manufacturer bortezomib tablets bortezomib injection tablets price manufacturing possibilities medicine health uses bortezomib trials bortezomib manufacturing bortezomib India trading bortezomib product bortezomib supplier supple suppliers vendor vendors price prices | Taj Pharma Group

ABOUT

Norvelzo, Bortezomib - Injection. Norvelzo, Bortezomib - Injection NORVELZO® (BORTEZOMIB FOR INJECTION) is used to treat multiple myeloma and mantle cell lymphoma. NORVELZO® 1mg / 2mg / 3.5 mg in combination with melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for high-dose chemotherapy with haematopoietic stem cell transplantation. This leaflet answers some common questions about NORVELZO® Powder for Injection. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you being given NORVELZO® against the benefits this medicine is expected to have for you.If you have any concerns about being given NORVELZO® ask your doctor. Keep this leaflet while being treated. You may need to read it again.
Read more..
Patient Information  bortezomib pdf icon Full Prescribing Information  bortezomib pdf icon
  • Bortezomib (Norvelzo -logo)
  • taj logo
  • Bortezomib injection(Norvelzo -logo)
  • Bortezomib injection-taj logo
  • NORVELZO 1mg (Bortezomib injection)Powder for solution for injection
  • NORVELZO 2mg (Bortezomib injection)Powder for solution for injection
  • NORVELZO 3.5 mg (Bortezomib injection)Powder for solution for injection
(Bortezomib injection) - feedback

About NORVELZO
NORVELZO® (BORTEZOMIB FOR INJECTION) 1mg / 2mg / 3.5 mg in combination with melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for high-dose chemotherapy with haematopoietic stem cell transplantation. - White to off-white cake or powder. NORVELZO 3.5 mg as monotherapy is indicated for the treatment of adult patients with progressive multiple myeloma who have received at least 1 prior therapy and who have already undergone or are unsuitable for 3.5 MG BORTEZOMIB (as a mannitol boronic ester). NORVELZO 3.5 mg in combination with melphalan and prednisone is indicated for the treatment of adult patients with previously untreated multiple myeloma who are not eligible for high-dose chemotherapy with haematopoietic stem cell transplantation.

About Taj Pharma Group
Taj Pharma is one of the leading generic and branded pharmaceutical manufacturing company in India. We hold top positions in different established markets worldwide and are building a strong presence in many emerging generics markets. We have eight manufacturing sites in India to support our market standing, holding a strong regulatory position and major certifications for most markets. Today, we market more than 500 branded and 4600 generics compositions to consumers in more than 40 countries and territories across the globe. Our products cover a vast array of therapeutic categories, and we offer an extensive range of dosage forms and delivery systems including oral solids, controlled-release, steriles, injectables, topicals, liquids, transdermals, semi-solids and high-potency products.

Twitter Facebook LinkedIn plusone.google

Copyright 2019 Taj Pharmaceuticals Limited. All rights reserved.
NORVELZO® is Registered Trade Mark of Taj Pharma India 2009-2019
This site contains medical information that is intended for doctors or medical practitioner only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns. Use and access of this site is subject to the terms and conditions as set out in our Privacy Policy and Terms of Use.
© Copyright 2019 Taj Pharmaceuticals Limited (India),. All Rights Reserved.Bortezomib Injection - taj logo

Taj Pharma Group

Taj
Pharmaceuticals India
Pharmaceuticals Manufacturing Company Taj API
Active Pharmaceuticals Ingredients Taj Agro
FMCG Company India Taj Drugs
Generics Pharmaceuticasls Exporter Taj Lifesciences
Lifesciences Company Taj Hospitals
Hospitals in India Taj For Doctors
Information to Patients and Doctors